Evidence map›Paper›PMID 36819611›Full record

ArticleRegenerative therapy2023

Laser emission at 675 nm: In vitro study evidence of a promising role in skin rejuvenation.

Giada Magni, Laura Pieri, Irene Fusco, Francesca Madeddu, Tiziano Zingoni, Francesca Rossi

Open access · goldAbstract read
In one paragraph

Article in Regenerative therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. High-powered 675-nm laser: Safety and efficacy in clinical evaluation and in vitro evidence for different skin disorders.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
    Article
  11. Clinical application of 675 nm laser therapy for dorsal hand skin hyperpigmentation.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2023
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Giada MagniIstituto di Fisica Applicata "Nello Carrara", Consiglio Nazionale delle Ricerche (CNR - IFAC), Via Madonna del Piano, 10, Sesto Fiorentino, Firenze, 50019, Italy.
Laura PieriEl.En. Group, Via Baldanzese, 17, 50041, Calenzano, Italy.
Irene FuscoEl.En. Group, Via Baldanzese, 17, 50041, Calenzano, Italy.
Francesca MadedduEl.En. Group, Via Baldanzese, 17, 50041, Calenzano, Italy.
Tiziano ZingoniEl.En. Group, Via Baldanzese, 17, 50041, Calenzano, Italy.
Francesca RossiIstituto di Fisica Applicata "Nello Carrara", Consiglio Nazionale delle Ricerche (CNR - IFAC), Via Madonna del Piano, 10, Sesto Fiorentino, Firenze, 50019, Italy.
El.En. Group (Italy) · ITNello Carrara Institute of Applied Physics · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Light-based therapies have been proven to influence and perhaps reverse skin ageing at clinical, molecular and histologic levels. Laser technology decreases photodamage by promoting collagen type I and III synthesis and enhancing the expression of heat shock protein.

Indexed as

675-nm laser wavelengthConfocal microscopyLaser treatmentNeocollagenesisSkin agingSkin resurfacing

Identifiers

PMID36819611
PMCPMC9930151
OpenAlexW4320810938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.